Archives‎ > ‎

Aluminum In Vaccines May Cause Autism According To Experts in New Study, from Peter Myers

(1) Aluminum In Vaccines May Cause Autism According To Experts in New Study(2) Perhaps we now have the link between Vaccination and Autism - Daily Mail(3) Aluminium and autism - by Professor Chris Exley in The Hippocratic Post(4) Researchers should test Vaccines for Mercury as well - Gary Kohls M.D.(1) Aluminum In Vaccines May Cause Autism According To Experts in New Studyhttps://www.activistpost.com/2017/12/aluminum-in-vaccines-may-cause-autism-according-to-experts.htmlDECEMBER 1, 2017By Aaron KeselA new controversial study confirms aluminum in vaccines may cause Autism Spectrum Disorder (ASD), and those children who suffer from it to have up 10 times more metal in their brains than what is considered a safe amount for adults. But is anyone surprised that metals cause deficiency in one’s own body?Mercury and aluminum have long been debated by people like Robert Kennedy Jr. as ingredients in vaccines that could cause autism; and for good reason since we know that both aluminum and Mercury are neurotoxins that harm the body at high levels. But now researchers have discovered that aluminum causes the membrane to separate the brain from blood flowing to it, thus affecting its internal temperature, non-neuronal cells and inflammatory cells, Daily Mail reported."Perhaps we now have the link between vaccination and autism spectrum disorder (ASD), the link being the inclusion of an aluminium adjuvant in the vaccine," Professor Chris Exley from Keele University said.The scientists hypothesize that children who suffer from autism may suffer from some strange genetic change that cause them to accumulate aluminum within their bodies. The study was published in the Journal of Trace Elements in Medicine and Biology.Another study in 2012 from the peer-reviewed medical journal Lupus by Lucija Tomljenovic, PhD and Christopher A. Shaw, PhD of the University of British Columbia corroborates what Professor Chris Exley published, indicating that aluminum toxicity targets the mitochondria. The experiment found evidence that aluminum as an adjuvant can lead to permanent detrimental alterations of the brain and immune system function.Aluminum is known to cause an "etiology of a number of diseases including Alzheimer’s, Parkinson’s, dialysis encephalopathy, and osteomalacia. Al has been shown to exert its effects by disrupting lipid membrane fluidity, perturbing iron (Fe), magnesium, and calcium homeostasis, and causing oxidative stress," according to the abstract of the 2012 study.This is also on point with what many court rulings have found as well in relation to vaccines causing autism in once-healthy kids.One case in an Italian court in September, 2014, "ruled mercury and aluminum in vaccines cause autism" and awarded a plaintiff’s family compensation for their young boy who developed autism from a six-in-one hexavalent vaccine manufactured by GlaxoSmithKline. GSK even admits INFANRIX Hexa can cause several deadly illnesses, but insists that its risk-benefit profile "continues to be favorable." In 2013, two kids were awarded millions by the vaccine court, confirming the MMR vaccine causes autism.So what is the probability that the MMR vaccine causes autism?  Is there any research that suggest the vaccine could potentially cause autism in kids? Yes, there is a ton of evidence including court cases, various studies, whistleblowers and quotes by health community officials themselves.This is all on record if you really want to dig. But I figured I’d do the digging for you, so you can follow along and check my research and understand where all this comes from and decide for yourself.A senior CDC official, Dr. William Thompson stated vaccination’s links to autism and released 1,000 documents to back his claims.This issue has actually been known since the 1960s that the MMR vaccine causes autism and has been admitted publicly."Rubella (congenital rubella syndrome) is one of the few proven causes of autism," Walter A. Orenstein, M.D., former Assistant Surgeon General and Director of the National Immunization Program, said in a 2002 letter to the UK’s Chief Medical Officer.Then in 1998, a study by Dr. Andrew Wakefield and colleagues published in the respected medical journal the Lancet allegedly found a supposed link with autism and bowel disease which has since been retracted and called an elaborate fraud. Although research by Mercola found that new evidence refutes fraud findings in Dr. Wakefield’s Case.This is the same Andrew Wakefield who was also the director of the censored movie VAXXED: From Cover-up to Catastrophe.In 2015, the aforementioned CDC whistleblower Dr. William Thompson confirmed the previous claims made by Dr. Andrew Wakefield in 1998. Thompson alleges that his colleagues in a 2004 study by the U.S. Centers for Disease Control covered up and destroyed 2004 study documents that showed a significant link between the MMR vaccine (measles, mumps and rubella) and autism in African American boys vaccinated before 36 months."The omitted data suggested that African American males who received the MMR vaccine before age 36 months were at increased risk for autism." ~CDC Senior Scientist Dr. William ThompsonIf that’s not enough, after the revelation by the CDC whistleblower other doctors have questioned the MMR vaccine’s safety. Even Dr. Peter Fletcher, former Chief Scientific Officer at the Department of Health in the UK, says there are "thousands of documents" that are being ignored that prove the dangers of the MMR vaccine."The refusal by governments to evaluate the risks properly will make this one of the greatest scandals in medical history," Dr. Peter Fletcher said."It’s time to clean up the CDC cesspool Dr. Thompson must speak, under oath. We all need to email the Congressional Oversight and Reform Office today and request that Dr. Thompson be issued a subpoena. If the CDC intentionally hid the data that the MMR vaccine was associated with autism, then CDC heads need to roll this needs to end now," Dr. Brownstein, a top doctor said.Further evidence that could lead to a link that the aluminum adjuvant causes ADS is a court ruling in the UK which found that the Swine Flu vaccinations had caused brain damage and Guillain-Barre syndrome (GBS) in multiple kids in 2015  who took the jab.Using aluminum and other metals in vaccines as an adjuvant may be part of a 90-year-old experiment where we were all the lab rats.Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. We hope that the present paper will provide a framework for a much needed and long overdue assessment of this highly contentious medical issue. – US National Library of Medicine National Institutes of Health.This all also comes after the CDC suggested there might be a link between miscarriages and vaccinations as I reported for Natural Blaze in early September.For a list of vaccines that still contain mercury and aluminum above EPA safety levels click here. Seven vaccines are reported to still contain thimerosal, which is 49.5% mercury.Why has it taken us so long to ask if injecting known neurotoxins into the bodies of infants and children is safe when the US National Library of Medicine National Institutes of Health has admitted their understanding of aluminum as a main adjuvant in vaccines is "poor"?(2) Perhaps we now have the link between Vaccination and Autism - Daily Mailhttp://www.dailymail.co.uk/health/article-5133049/Aluminium-vaccines-cause-autism.htmlProfessor reveals aluminium in jabs may cause sufferers to have up 10 times more of the metal in their brains than is safeAluminium crosses the membrane that separates the brain from blood The metal accumulates in cells that maintain a constant internal environment Autism sufferers may have genetic changes that cause them to hold aluminium Disgraced doctor Andrew Wakefield linked autism to the MMR vaccine in 1995 His views are widely discredited, but the WHO says vaccine fears put many offBy PROFESSOR CHRIS EXLEY FOR THE HIPPOCRATIC POST and ALEXANDRA THOMPSON HEALTH REPORTER FOR MAILONLINEAluminium in vaccines may cause autism, controversial new research suggests.Autistic children have up to 10 times more of the metal in their brains than what is considered safe in adults, a study found.Aluminium crosses the membrane that separates the brain from circulating blood and accumulates in cells involved in maintaining a constant internal environment, such as temperature, the research adds.Study author Professor Chris Exley from Keele University, said: 'Perhaps we now have the link between vaccination and autism spectrum disorder (ASD), the link being the inclusion of an aluminium adjuvant in the vaccine.'The researchers speculate autism sufferers may have genetic changes that cause them to accumulate aluminium which healthy people are able to remove.The findings are controversial after the disgraced gastroenterologist Andrew Wakefield said in 1995 that the measles, mumps and rubella (MMR) vaccine is linked to bowel disease and autism.Mr Wakefield's view has since been widely discredited, however, the World Health Organization claims people's fear of vaccines means many, particularly young children, are unprotected against measles.In a piece for The Hippocratic Post, Professor Exley discusses how aluminium accumulates in the brains of autism sufferers and if vaccines may be to blame.Aluminium enters the brain and accumulatesResearch at Keele University, published in the Journal of Trace Elements in Medicine and Biology, provides the strongest indication yet that aluminium is a cause of ASD.The aluminium content of brain tissues from five donors who died with a diagnosis of ASD was found to be extraordinarily high; some of the highest values yet measured in human brain tissue.Why for example, would one of the four major brain lobes of a 15-year-old boy with autism be 8.74 (11.59) micrograms/g dry weight - a value which is at least 10 times higher than might be considered as acceptable for an adult never mind a child?Yet, while the aluminium content of each of the five brains was shockingly high it was the location of the aluminium in the brain tissue which served as the standout observation.The majority of aluminium was identified in non-neuronal cells, which are involved in maintaining a constant internal environment.Aluminium was also found in inflammatory cells in the brain, alongside clear evidence of inflammatory cells heavily loaded with aluminium entering the brain via the surrounding membranes and those that separate the brain from circulating blood.The fact that the majority of aluminium found in brain tissues in ASD was within cells and associated with tissues that maintain the body's internal environment is, at least for now, unique to ASD and may begin to explain why young adolescents had so much aluminium in their brains.Autism sufferers may be less able to remove built-up aluminiumPerhaps there is something within the genetic make-up of specific individuals which predisposes them to accumulate and retain aluminium in their brain, as is similarly suggested for individuals with genetically passed-on Alzheimer’s disease.The new evidence strongly suggests aluminium is entering the brain in ASD via inflammatory cells which have become loaded up with aluminium in the blood and/or lymph, much as has been for certain immune cells at injection sites for vaccines that contain aluminium to increase the body's immune response.This article was originally published by The Hippocratic Post and reproduced with their permission.(3) Aluminium and autism - by Professor Chris Exley in The Hippocratic Posthttps://www.hippocraticpost.com/infection-disease/aluminium-and-autism/by Professor Chris ExleyThe Hippocratic Post, 30th November 2017Does human exposure to aluminium  have a role to play in autism spectrum disorder (ASD)? Research at Keele University published in the Journal of Trace Elements in Medicine and Biology provides the strongest indication yet that aluminium is an aetiological agent in ASD. The aluminium content of brain tissues from 5 donors who died with a diagnosis of ASD was found to be extraordinarily high, some of the highest values yet measured in human brain tissue. Why for example, would the occipital lobe of a 15 year old boy with autism be 8.74 (11.59) micrograms/g dry wt., a value which is at least 10 times higher than might be considered as acceptable for an aged adult never mind a child?However, while the aluminium content of each of the 5 brains was shockingly high it was the location of the aluminium in the brain tissue which served as the standout observation. The majority of aluminium was identified inside non-neuronal cells including microglia and astrocytes.However, while the aluminium content of each of the 5 brains was shockingly high it was the location of the aluminium in the brain tissue which served as the standout observation. The majority of aluminium was identified inside non-neuronal cells including microglia and astrocytes.Aluminium was also found in lymphocytes in the meninges and in similar inflammatory cells in the vasculature. There was clear evidence of inflammatory cells heavily loaded with aluminium entering the brain via the meningeal membranes and the blood-brain-barrier.The fact that the majority of aluminium found in brain tissues in ASD was intracellular and associated with non-neuronal cells is, at least for now, unique to ASD and may begin to explain why young adolescents had so much aluminium in their brains.The fact that the majority of aluminium found in brain tissues in ASD was intracellular and associated with non-neuronal cells is, at least for now, unique to ASD and may begin to explain why young adolescents had so much aluminium in their brains.Perhaps there is something within the genetic make-up of specific individuals which predisposes them to accumulate and retain aluminium in their brain, as is similarly suggested for individuals with familial Alzheimer’s disease. The new evidence strongly suggests that aluminium is entering the brain in ASD via pro-inflammatory cells which have become loaded up with aluminium in the blood and/or lymph, much as has been demonstrated for monocytes at injection sites for vaccines including aluminium adjuvants. Perhaps we now have the putative link between vaccination and ASD, the link being the inclusion of an aluminium adjuvant in the vaccine.Professor Chris ExleyProfessor in Bioinorganic Chemistry Keele UniversityHonorary Professor, UHI Millennium InstituteGroup Leader - Bioinorganic Chemistry Laboratory at Keele(4) Researchers should test Vaccines for Mercury as well - Gary Kohls M.D.Note that the authors of the new research paper are being very charitable (or cautious, logically fearful about being "wakefielded" by Big Pharma’s trolls that seem to be everywhere these days) about drawing the obvious conclusion that the autistic victims whose brains were tested were certain to have been fully vaccinated starting in infancy (especially the brain of the 15 year-old autistic boy). It is important to note that the aluminum remained in the brain for years.It would be interesting for the authors to go back and obtain the clinical information about vaccinations and perhaps test for mercury as well. Orally ingested aluminum rarely reaches the blood stream, much less comes in contact with or able to cross the brain-brain barrier (unless the BBB has been sickened by any number of cellular toxins – including aluminum and mercury) whereas intramuscularly injected aluminum adjuvants can easily get into the brain, via macrophages and other white blood cells that naturally ingest the antigens that have aluminum adjuvants adsorbed (as foreign body) and are then able to eventually cross the blood-brain barrier through the BBB tight junctions, along with the ingested aluminum and adsorbed antigensHopefully we will hear analyses of this paper from Dr Gherardi, Dr Shoenfeld, Dr Shaw, Dr Tomljenovic and some of the other experts on aluminum and vaccine neurotoxicity. (Note that "aluminum" is spelled "aluminium" in Britain and pronounced with 5 syllables.) GaryAluminium in Brain Tissue in AutismMatthew Mold (a), Dorcas Umar (b), Andrew King (c), Christopher Exley (a)a.The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire, ST5 5BG, United Kingdom. b) Life Sciences, Keele University, Staffordshire, ST5 5BG, United Kingdom. c) Department of Clinical Neuropathology, Kings College Hospital, London, SE5 9RS, United Kingdom.https://worldmercuryproject.org/wp-content/uploads/Mold-2017-Aluminum-in-Brain-Tissue-and-Autism.pdfKeywords: Human exposure to aluminium; human brain tissue; autism spectrum disorder; transversely heated atomic absorption spectrometry; aluminium-selective fluorescence microscopyABSTRACTAutism spectrum disorder is a neurodevelopmental disorder of unknown aetiology. It is suggested to involve both genetic susceptibility and environmental factors including in the latter environmental toxins. Human exposure to the environmental toxin aluminium has been linked, if tentatively, to autism spectrum disorder. Herein we have used transversely heated graphite furnace atomic absorption spectrometry to measure, for the first time, the aluminium content of brain tissue from donors with a diagnosis of autism. We have also used an aluminium-selective fluor to identify aluminium in brain tissue using fluorescence microscopy. The aluminium content of brain tissue in autism was consistently high. The mean (standard deviation) aluminium content across all 5 individuals for each lobe were 3.82(5.42), 2.30(2.00), 2.79(4.05) and 3.82(5.17) mg/g dry wt. for the occipital, frontal, temporal and parietal lobes respectively. These are some of the highest values for aluminium in human brain tissue yet recorded and one has to question why, for example, the aluminium content of the occipital lobe of a 15 year-old boy would be 8.74 (11.59) mg/g dry wt.?Aluminium-selective fluorescence microscopy was used to identify aluminium in brain tissue in 10 donors. While aluminium was imaged associated with neurones it appeared to be present intracellularly in microglia-like cells and other inflammatory non-neuronal cells in the meninges, vasculature, grey and white matter. The pre-eminence of intracellular aluminium associated with non-neuronal cells was a standout observation in autism brain tissue and may offer clues as to both the origin of the brain aluminium as well as a putative role in autism spectrum disorder.1.IntroductionAutism spectrum disorder (ASD) is a group of neurodevelopmental conditions of unknown cause. It is highly likely that both genetic [1] and environmental [2] factors are associated with the onset and progress of ASD while the mechanisms underlying its aetiology are expected to be multifactorial [3-6]. Human exposure to aluminium has been implicated in ASD with conclusions being equivocal [7-10]. To-date the majority of studies have used hair as their indicator of human exposure to aluminium while aluminium in blood and urine have also been used to a much more limited extent. Paediatric vaccines that include an aluminium adjuvant are an indirect measure of infant exposure to aluminium and their burgeoning use has been directly correlated with increasing prevalence of ASD [11]. Animal models of ASD continue to support a connection with aluminium and to aluminium adjuvants used in human vaccinations in particular [12]. Hitherto there are no previous reports of aluminium in brain tissue from donors who died with a diagnosis of ASD. We have measured aluminium in brain tissue in autism and identified the location of aluminium in these tissues.RESULTS3.1. Aluminium content of brain tissuesThe aluminium content of all tissues ranged from 0.01 (the limit of quantitation) to 22.11mg/g dry wt. (Table 1). The aluminium content for whole brains (n=4 or 5 depending upon the availability of hippocampus tissue) ranged from 1.20 (1.06) mg/g dry wt. for the 44 year-old female donor (A1) to 4.77 (4.79) mg/g dry wt. for a 33 year-old male donor (A5). Previous measurements of brain aluminium, including our 60 brain study [15], have allowed us to define loose categories of brain aluminium content beginning with ?1.00 mg/g dry wt. as pathologically benign (as opposed to ‘normal’). Approximately 40% of tissues (24/59) had an aluminium content considered as pathologically-concerning (?2.00 mg/g dry wt.) while approximately 67% of these tissues had an aluminium content considered as pathologically significant (?3.00 mg/g dry wt.). The brains of all 5 individuals had at least one tissue with a pathologically significant content of aluminium. The brains of 4 individuals had at least one tissue with an aluminium content ?5.00 mg/g dry wt. while 3 of these had at least one tissue with an aluminium content ?10.00 mg/g dry wt. (Table 1). The mean (SD) aluminium content across all 5 individuals for each lobe were 3.82(5.42), 2.30(2.00), 2.79(4.05) and 3.82(5.17) mg/g dry wt. for the occipital, frontal, temporal and parietal lobes respectively. There were no statistically significant differences in aluminium content between any of the 4 lobes.3.2. Aluminium fluorescence in brain tissuesWe examined serial brain sections from 10 individuals (3 females and 7 males) who died with a diagnosis of ASD and recorded the presence of aluminium in these tissues (Table S1). Excitation of the complex of aluminium and lumogallion emits characteristic orange fluorescence that appears increasingly bright yellow at higher fluorescence intensities. Aluminium, identified as lumogallion-reactive deposits, was recorded in at least one tissue in all 10 individuals. Autofluorescence of immediately adjacent serial sections confirmed lumogallion fluorescence as indicative of aluminium. Deposits of aluminium were significantly more prevalent in males (129 in 7 individuals) than females (21 in 37 individuals). Aluminium was found in both white (62 deposits) and grey (88 deposits) matter. In females the majority of aluminium deposits were identified as extracellular (15/21) whereas in males the opposite was the case with 80 out of 129 deposits being intracellular. We were only supplied with 3 serial sections of each tissue and so we were not able to do any staining for general morphology which meant that it was not always possible to determine which subtype of cell was showing aluminium fluorescence.Aluminium-loaded mononuclear white blood cells, probably lymphocytes, were identified in the meninges and possibly in the process of entering brain tissue from the lymphatic system (Fig.1). Aluminium could be clearly seen inside cells as either discrete punctate deposits or as bright yellow fluorescence. Aluminium was located in inflammatory cells associated with the vasculature (Fig. 2). In one case what looks like an aluminium-loaded lymphocyte or monocyte was noted within a blood vessel lumen surrounded by red blood cells while another probable lymphocyte showing intense yellow fluorescence was noted in the adventitia (Fig. 2b). Glial cells including microglia-like cells that showed positive aluminium fluorescence were often observed in brain tissue in the vicinity of aluminium-stained extracellular deposits (Figs. 3&4). Discrete deposits of aluminium approximately 1mm in diameter were clearly visible in both round and amoeboid glial cell bodies (e.g. Fig. 3b). Intracellular aluminium was identified in likely neurones and glia-like cells and often in the vicinity of or co-localised with lipofuscin (Fig. 5). Aluminium-selective fluorescence microscopy was successful in identifying aluminium in extracellular and intracellular locations in neurones and non-neuronal cells and across all brain tissues studied (Figs.1-5). The method only identifies aluminium as evidenced by large areas of brain tissue without any characteristic aluminium-positive fluorescence (Fig. S1).4. DiscussionThe aluminium content of brain tissues from donors with a diagnosis of ASD was extremely high (Table 1). While there was significant inter-tissue, inter-lobe and inter-subject variability the mean aluminium content for each lobe across all 5 individuals was towards the higher end of all previous (historical) measurements of brain aluminium content, including iatrogenic disorders such as dialysis encephalopathy [13,15, 16-19]. All 4 male donors had significantly higher concentrations of brain aluminium than the single female donor. We recorded some of the highest values for brain aluminium content ever measured in healthy or diseased tissues in these male ASD donors including values of 17.10, 18.57 and 22.11 mg/g dry wt. (Table 1). What discriminates these data from other analyses of brain aluminium in other diseases is the age of the ASD donors. Why, for example would a 15 year-old boy have such a high content of aluminium in their brain tissues? There are no comparative data in the scientific literature, the closest being similarly high data for a 42 year-old male with familial Alzheimer’s disease (fAD) [19]. Aluminium-selective fluorescence microscopy has provided indications as to the location of aluminium in these ASD brain tissues (Figs. 1-5). Aluminium was found in both white and grey matter and in both extra- and intracellular locations. The latter were particularly preeminent in these ASD tissues. Cells that morphologically appeared non-neuronal and heavily loaded with aluminium were identified associated with the meninges (Fig. 1), the vasculature (Fig. 2) and within grey and white matter (Figs. 3-5). Some of these cells appeared to be glial (probably astrocytic) whilst others had elongated nuclei giving the appearance of microglia [5]. The latter were sometimes seen in the environment of extracellular aluminium deposition. This implies that aluminium somehow had crossed the blood-brain barrier and was taken up by a native cell namely the microglial cell. Interestingly, the presence of occasional aluminium-laden inflammatory cells in the vasculature and the leptomeninges opens the possibility of a separate mode of entry of aluminium into the brain i.e. intracellularly. However, to allow this second scenario to be of significance one would expect some type of intracerebral insult to occur to allow egress of lymphocytes and monocytes from the vasculature. The identification herein of non-neuronal cells including inflammatory cells, glial cells and microglia loaded with aluminium is a standout observation for ASD. For example, the majority of aluminium deposits identified in brain tissue in fAD were extracellular and nearly always associated with grey matter [19]. Aluminium is cytotoxic [21] and its association herein with inflammatory cells in the vasculature, meninges and central nervous system is unlikely to be benign. Microglia heavily loaded with aluminium while potentially remaining viable, at least for some time, will inevitably be compromised and dysfunctional microglia are thought to be involved in the aetiology of ASD [22], for example in disrupting synaptic pruning [23]. In addition the suggestion from the data herein that aluminium entry into the brain via immune cells circulating in the blood and lymph is expedited in ASD might begin to explain the earlier posed question of why there was so much aluminium in the brain of a 15 year old boy with an ASD. A limitation of our study is the small number of cases that were available to study and the limited availability of tissue. Regarding the latter, having access to only 1g of frozen tissue and just 3 serial sections of fixed tissue per lobe would normally be perceived as a significant limitation. Certainly if we had not identified any significant deposits of aluminium in such a small (the average brain weighs between 1500 and 2000g) sample of brain tissue then such a finding would be equivocal. However, the fact that we found aluminium in every sample of brain tissue, frozen or fixed, does suggest very strongly that individuals with a diagnosis of ASD have extraordinarily high levels of aluminium in their brain tissue and that this aluminium is pre-eminently associated with non-neuronal cells including microglia and other inflammatory monocytes.5. ConclusionsWe have made the first measurements of aluminium in brain tissue in ASD and we have shown that the brain aluminium content is extraordinarily high. We have identified aluminium in brain tissue as both extracellular and intracellular with the latter involving both neurones and non-neuronal cells. The presence of aluminium in inflammatory cells in the meninges, vasculature, grey and white matter is a standout observation and could implicate aluminium in the aetiology of ASDReferences (# 23) and Images available at https://worldmercuryproject.org/wp-content/uploads/Mold-2017-Aluminum-in-Brain-Tissue-and-Autism-- Peter Myerswebsite: http://mailstar.net/index.html